|

Medical Release Print

AUTHORIZING Patient’s NAME (please print): Last: __________________ First ______________ M.I.___

     Date of Birth: ___________________ Social Security #: ______ – _____ – ______

AUTHORIZATION FOR RELEASE OF INFORMATION AND DISCUSSION BETWEEN

National Alliance of Methadone Advocates (NAMA)
435 Second Avenue
New York, NY 10010
tel/fax: 212 595-6262

AND

_____________________________________________  (Person/Facility)
______________________________________________   (Address)
______________________________________________   (Address)
______________________________________________  (City, ST, Zip)
(telephone)  ____________________   (fax)  ___________________

WE REQUEST ALL PERTINENT MEDICAL RECORDS FROM ATTENDING PHYSICIANS, HOSPITALS AND OTHER HEALTH CARE PROVIDERS. THE PURPOSE OF THIS RELEASE IS TO ALLOW WRITTEN AND/OR VERBAL COMMUNICATION PERTAINING TO MEDICAL INFORMATION INCLUDING BUT, NOT LIMITED TO: clinical and discharge summaries, other complaints, counselors notes, medical orders, the results of medical and psychiatric evaluations, case reports and psychological assessments. THIS RELEASE ALSO AUTHORIZES COMMUNICATIONS in verbal or written form between NAMA and its representatives ______________________ and the above named person facility or facility representatives pursuant to the patient listed above. This authorization may be withdrawn in writing at any time and terminates on _______________________.**

ADDITIONAL INFORMATION REQUIRED: ________________________________________________
______________________________________________________________________________
______________________________________________________________________________

I understand that information specific to my medical history can be released with this consent. I can cancel this consent at any time but I understand the cancellation will not affect any information previously released under the agreement. I further understand that my notice of cancellation must be in writing.

I understand that information about my case is confidential and protected under the Federal regulations governing confidentiality of Alcohol and Drug Abuse Patient Records, 42CFR, Part 2 and 45 CFR, Parts 160 and 164 and cannot be disclosed without my written consent unless otherwise provided for in the regulations. I approve the release of this information. I understand what this agreement means and I am satisfied with my explanations which I may have requested and received.

________________________________

Signature of Patient
__________________________________
Signature of Witness
________________________________

Printed name
__________________________________
Printed name
________________________________

Date of Signature
__________________________________
Date of Signature

**  According to HIPPA the new patient privacy regulations a release must have a specific start time and end time which should not be more than one (1) year for compliancy.

© Copyright 2004 National Alliance of Methadone Advocates
wmethadone.org   Last Update: February 15, 2004

Similar Posts

  • TEXNAMA

    Admin 08/25/2021

    Texas Alliance of Methadone Advocates We are dedicated to educating all methadone patients, counselors, familes, employers about the benefits of methadone. We are volunteers made up of patients, ex-patients, family members, employers, counselors, providers, doctors and you. We want to end the stigma associated with being on Methadone Maintence Treatment (MMT) by educating both patients…

  • The National Methadone Conference-3

    Admin 05/13/2023

    American Association for the Treatment of Opioid Dependence Washington, D.C. ~ April 13-16, 2003 Session: Organizational Meeting April 15, 2003 Picture Essay of NAMA’s Organizational Meeting Starting the Meeting Joyce calls the meeting to order. Top (l-r) Robert Sanders (NYC NAMA), Becki Ballard (OK NAMA), Gary Nessenbaum (WAMM), Jennifer Nelson Connelly (PA NAMA), Joycelyn Woods,…

  • National Alliance for Medication Assisted Recover 435 Second Avenue New York, NY 10010      

    Admin 03/29/2022

    Membership Application Name:   _______________________________________________________   Mr. ___  Ms. ___  Dr. ___ Organization:  __________________________________________________________________________ Title:  _____________________________________________  Degree(s):  ________________________ Address:  _____________________________________________________________________________ Address:  _____________________________________________________________________________ City:   __________________________________   State:   ____________   Postal Code:   _____________ Email:  ______________________________________  Country:   ________________________________ Home Phone: (____)___________________________   Work Phone:  (____)_______________________ Alternate Phone:  (____)________________________   Fax:  (____)______________________________ If you have email may we send you bulletin alerts electronically. (This will get bulletin alerts to you quicker than usual mail)   Yes  _____   No _____ Types of Membership $_______ Individual Membership   Dues: $25 a…

  • Making Methadone Safe

    Admin 08/05/2022

    p3″ align=”center”>References American Association for the Treatment of Opiate Dependence. QTc Interval Screening – AATOD Policy and Guidance Statement (March 30, 2009). Available from AATOD, 225 Varick Street, New York, NY 10014. Black, L. DEA officials visit Waukegan clinic during probe of methadone death. Chicago Tribune (August 7, 2009). Omaha News Staff. Father Believes Son…